News
A vaccine that blocks infection with the human papillomavirus has helped to lower cervical cancer rates. Researchers want to ...
The MyHPVscore test represents a successful translation of research from the laboratory to clinical practice. A Michigan ...
Anal cancer incidence is on the rise in the United States, with the most pronounced increases among older white and Hispanic women, according to research presented at Digestive Disease Week.These ...
Every 2 years, researchers from the American Cancer Society (ACS) publish a comprehensive report using data from multiple ...
The combination of toripalimab, nimotuzumab, and chemotherapy has shown promise as neoadjuvant treatment for patients with high-risk, locally advanced penile cancer, according to researchers.
Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026Mecbotamab vedotin (Mec-V; ...
A new research paper was published in Oncotarget, Volume 16, on April 24, 2025, titled “PD-L1 and FOXP3 expression in ...
Some physicians recommend annual examinations for HIV-positive men (HIV is ... these cells for any early signs of cancer. Although most experts acknowledge HPV vaccines’ effectiveness, Robert ...
Did you know there's a way to eliminate cervical cancer? A group of Alabamians are coming together to share how. Learn more 👇 NowPartner #cervicalcancer #cancer #UAB CH ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results